|
Our product systems use miniature wireless sensors – just
2 mm in diameter and 18 mm long – implanted into unresectable, solid-mass
tumors using minimally invasive procedures. The sensors gather data on tumor
cell kinetics and physiology; wireless technology with radio frequency coupling
is then used to transfer the data to a hand-held monitor.
The systems can continuously monitor biological and physiological changes in
cell and organ systems. It is envisaged that this new technology will be able
to deliver data such as:
• the actual radiation dose hitting the tumor
• the uptake and retention of a particular chemotherapeutic agent
• the temperature during hyperthermia treatment
• the evaluation of combination therapies, monitoring the effects of
chemotherapy and radiation therapy, both individually and together
• the level of parameters such as pH or oxygen
Upon clearance by the FDA, Sicel’s sensor-based systems
will gather the data that clinicians and scientists believe will increase the
efficacy and efficiency of current and future cancer treatments.
For more information, please see our dedicated DVS® site,
http://www.dvssmartmarker.com
PressReleases
January 30,
2008 - New HCPCS Reimbursement Code for Implantable Radiation Dosimeter Makes
DVS Accessible to More Cancer Patients
April
12, 2006 - DVS Receives 510K Clearance for Breast Cancer
June
21, 2006 - FDA Clears DVS for Prostate Cancer
August 29, 2006 -
Lynn Cancer Institute
August
29, 2006 - Florida Cancer Centers
Related articles
A.S. Beddar, M. Salehpour, T.M. Briere, H. Hamidian, M.T. Gillin,
“Preliminary evaluation of implantable MOSFET radiation
dosimeters,” Phys. Med. Biol. 50:141-149 (2005).
C.W.
Scarantino, C.J. Rini, M. Aquino, T.B. Carrea, R.D. Ornitz, M.S. Anscher, R.D.
Black, “The initial clinical results of an in vivo dosimeter during
external beam radiation therapy,” Int. J. Radiat. Oncol. Biol. Phys.
62(2):606-613 (2005).
C.W. Scarantino, D.M.
Ruslander, C.J. Rini, G.G. Mann, H.T. Nagle, and R.D. Black, “An
implantable radiation dosimeter for use in external beam radiation
therapy,” Med. Phys. 31:2658-2671 (2004).
R.D. Black, C.W.
Scarantino, G.G. Mann, M.S. Anscher, and R.D. Ornitz, “An analysis of an
implantable dosimeter system for external beam therapy,” Int. J. of
Radiat. Oncol. Biol. Phys. 63(1):290-300 (2005).
T.M. Briere, A.S. Beddar, and M.T. Gillin,
“Evaluation of precalibrated implantable MOSFET radiation dosimeters for
megavoltage photon beams,” Med. Phys. 32(11):3346-9 (2005).
Beyer
GP, Scarantino CW, Prestidge BR, Sadeghi AG, Ansher MS, Moyed M, Carrea TB,
Sims M, and Black RD. Technical Evaluation of Radiation Dose Delivered in
Prostate Cancer Patients as Measured by an Implantable MOSFET Dosimeter. Int.
J. Radiation Oncology Biol. Phys., 2007. Vol 69, No 3, pp 925-935.
Beyer
GP, Mann GG, Pursley JA, Espenhahn ET, Fraisse C, Godfrey DJ, Olham M, Carrea
TB, Bolick N, and Scarantino SW. An Implantable MOSFET Dosimeter for the
Measurement of the Radiation Dose in Tissue during Cancer Therapy. IEEE Sensors
Journal. Jan 2008. Vol 8, No 1, pp 38-51.
|
OVERVIEW
DVS®